Status:

TERMINATED

A Clinical Investigation of the Copeland™ Humeral Resurfacing Head

Lead Sponsor:

Biomet Orthopedics, LLC

Conditions:

Osteoarthritis

Rheumatoid Arthritis

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to perform a five-year, prospective evaluation of the Copeland™ Humeral Resurfacing Head Prosthesis for outcome and durability. Relief of pain and restoration of function ...

Eligibility Criteria

Inclusion

  • Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis.
  • Rheumatoid arthritis
  • Correction of functional deformity
  • Reconstructable Rotator Cuff
  • Treatment of acute fracture of the humeral head
  • Traumatic arthritis

Exclusion

  • Patients less than 18 years.
  • Patients with rapid joint destruction, osteomalacia, osteoporosis, or marked bone loss, which would preclude proper fixation of the prosthesis.
  • Patients with marked bone loss apparent on roentgenogram.
  • Metabolic disorders, which may impair bone formation.
  • Patients who are pregnant.
  • Patients with an active or suspected infection in or around the shoulder or distant foci of infections, which may spread to the implant site.
  • Patients with severe instability or deformity of the ligaments and/or surrounding soft tissue, which would prelude stability of the prosthesis.
  • Patients who have had revision procedures where other devices or treatments have failed.
  • Patients with a highly communicable disease or diseases that may limit follow-up (e.g. immuno-compromised conditions, hepatitis, active tuberculosis, neoplastic disease, etc).
  • Patients unwilling or unable to comply with a rehabilitation program for a cemented or cementless partial or total shoulder replacement or who indicate difficulty or inability to return for follow-up visits prescribed by the study protocol.
  • Patients with previous shoulder surgery or conditions that may interfere with the partial or total shoulder replacement's survival or outcome.
  • Patients who qualify for inclusion in the study, but refuse consent to participate in the study.
  • Patients who have had a partial or total shoulder arthroplasty on the contralateral shoulder within the last year.

Key Trial Info

Start Date :

April 1 2004

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 1 2009

Estimated Enrollment :

34 Patients enrolled

Trial Details

Trial ID

NCT00698750

Start Date

April 1 2004

End Date

November 1 2009

Last Update

June 21 2017

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.